Recombinant human collagen type iii and methods of making and using the same
By designing specific amino acid sequences and optimizing codon bias, recombinant human type III collagen was expressed in Pichia pastoris, which solved the problem of low activity of recombinant collagen and achieved efficient transdermal absorption and significant effects in promoting skin repair and moisturizing.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-17
- Publication Date
- 2026-06-02
AI Technical Summary
In the existing technology, there are problems such as low activity of recombinant collagen during the preparation process and ineffective or inhibitory effect on the expression of some beneficial target proteins.
By designing recombinant human type III collagen with a specific amino acid sequence, expressing it in Pichia pastoris using genetic engineering technology, optimizing codon bias to improve expression efficiency, and performing appropriate chemical and fluorescent modifications, the product's high hydrophilicity and humanized characteristics are ensured.
It improved the transdermal absorption efficiency of recombinant human type III collagen, reduced the risk of allergic reactions, and significantly regulated gene expression in fibroblasts and keratinocytes, promoting cell proliferation and migration, and enhancing skin repair and moisturizing capabilities.
Smart Images

Figure CN121342961B_ABST
Abstract
Citation Information
Patent Citations
Collagen composition for skin substrate repair and skin care application thereof
CN119405556A
Recombinant III-type humanized collagen, encoding gene thereof, protein preparation, preparation method of protein preparation, application of recombinant III-type humanized collagen and encoding gene thereof, and skin care product
CN120157755A